Core Viewpoint - The company plans to issue convertible bonds to raise funds for expanding its operations and enhancing its competitiveness, in compliance with relevant laws and regulations [1][3][21] Section 1: Necessity of Issuing Securities - The company aims to meet its funding needs and enhance its core competitiveness through the issuance of convertible bonds [1][2] - The funds raised will be used for specific projects that align with the company's strategic goals [1] Section 2: Appropriateness of the Issuance Target - The issuance will target a wide range of investors, including individuals and institutions, ensuring compliance with legal standards [1][2] - Existing shareholders will have priority in the allocation of the bonds, with specific ratios to be determined based on market conditions [1][2] Section 3: Reasonableness of Pricing Principles - The pricing of the bonds will be determined based on market conditions and company performance, ensuring it aligns with regulatory requirements [1][2] - The initial conversion price will be set at a level that reflects the average trading price of the company's shares over a specified period [1][2] Section 4: Feasibility of the Issuance Method - The company has established a sound organizational structure and has demonstrated sufficient profitability to cover the interest on the bonds [3][5] - The funds raised will be allocated to projects that comply with national policies and regulations, ensuring responsible use of capital [3][21] Section 5: Fairness and Reasonableness of the Issuance Plan - The issuance plan has been carefully reviewed and approved by the board, aiming to enhance the company's business scale and profitability [21]

证券代码：600642 证券简称：申能股份 申能股份有限公司 向不特定对象发行可转换公司债券预案 二〇二五年八月 申能股份有限公司 向不特定对象发行可转换公司债券预案 公司声明 在虚假记载、误导性陈述或重大遗漏，并对本预案内容的真实性、准确性、完整 性承担个别和连带的法律责任。 由公司自行负责；因本次向不特定对象发行可转换公司债券引致的投资风险， 由投资者自行负责。 任何与之相反的声明均属不实陈述。 其他专业顾问。 定对象发行可转换公司债券相关事项的实质性判断、确认、批准或注册，本预 案所述本次向不特定对象发行可转换公司债券相关事项的生效和完成尚待上海 证券交易所审核通过并经中国证监会同意注册后方可实施。 申能股份有限公司 向不特定对象发行可转换公司债券预案 目 录 申能股份有限公司 向不特定对象发行可转换公司债券预案 释 义 本预案中，除非文意另有所指，下列简称具有如下特定含义： 释义项 指 释义内容 申能股份、发行人、 指 申能股份有限公司 公司、上市公司 本次发行 指 申能股份有限公司本次向不特定对象发行可转换公司债券 预案、本预案 指 申能股份有限公司向不特定对象发行可转换公司债券预案 可转债 指 可 ...

第十二次会议，审议通过了《关于公司符合向不特定对象发行可转换 公司债券条件的议案》。 证券代码：600642 股票简称：申能股份 公告编号：2025-031 申能股份有限公司 第十一届董事会第十五次会议决议公告 申能股份有限公司第十一届董事会第十五次会议于 2025 年 8 月 董事。会议应到董事 11 名，参加表决董事 11 名，公司高级管理人员 列席了会议。会议符合《公司法》和《公司章程》有关规定。会议由 董事长华士超主持，审议并通过了以下决议： 可转换公司债券条件的议案》，并同意提交股东会审议。 次会议，审议通过了《关于公司符合向不特定对象发行可转换公司债 券条件的议案》，并同意提交董事会审议。 可转换公司债券方案的议案》，并同意提交股东会逐项审议。 次会议，审议通过了《关于公司向不特定对象发行可转换公司债券方 案的议案》，并同意提交董事会审议。 第十二次会议，审议通过了《关于公司向不特定对象发行可转换公司 债券方案的议案》。 换公司债券预案的议案》，并同意提交股东会审议。（具体内容详见 同日披露的《申能股份有限公司向不特定对象发行可转换公司债券预 案》） 次会议，审议通过了《关于公司向不特定对象发行可 ...

Core Viewpoint - Changgao Electric New Technology Co., Ltd. is applying to issue convertible bonds to unspecified objects and list them on the main board, with Huatai United Securities as the sponsor [1][2]. Group 1: Issuance Overview - The company intends to issue convertible bonds and has submitted the application documents in accordance with relevant laws and regulations [1][2]. - The total amount of funds to be raised is not to exceed 855.5782 million yuan, which will be used for specific projects [22][24]. Group 2: Sponsor Information - Huatai United Securities is the main underwriter, with representatives Liu Dong and Liu Tianji responsible for the recommendation [2][3]. - The sponsor has committed to conducting due diligence and ensuring the authenticity and completeness of the documents provided [9][10]. Group 3: Financial Health and Compliance - The company reported net profits of 57.9684 million yuan, 173.0765 million yuan, and 252.1039 million yuan for the years 2022, 2023, and 2024 respectively, indicating a strong financial position [15][18]. - The average distributable profit over the last three years is 161.0496 million yuan, which is sufficient to cover the interest payments on the bonds [15][17]. Group 4: Use of Proceeds - The raised funds will be allocated to the Changgao Electric New Jinzhou Production Base Phase III Project, the Changgao Electric New Wangcheng Production Base Upgrade and Expansion Project, and the Changgao Green Smart Distribution Industry Park Project [22][23]. - The company has established a management system for the raised funds to ensure compliance with the stated purposes [15][23]. Group 5: Regulatory Compliance - The issuance complies with the conditions set forth in the Securities Law and the Regulations on the Registration of Securities Issuance by Listed Companies [12][16]. - The company has fulfilled all internal decision-making procedures required for the issuance [11][12].

湖南启元律师事务所 关于 长高电新科技股份公司 向不特定对象发行可转换公司债券的 法律意见书 二〇二五年七月 致：长高电新科技股份公司 湖南启元律师事务所（以下简称"本所"）接受长高电新科技股份公司（以 下简称"长高电新"、"发行人"或"公司"）的委托，担任发行人申请向不特 定对象发行可转换公司债券（以下简称"本次发行"）的专项法律顾问。 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司证券 发行注册管理办法》《律师事务所从事证券法律业务管理办法》《律师事务所证 券法律业务执业规则（试行）》等法律、法规、规范性文件的有关规定，按照律 师行业公认的业务标准、道德规范和勤勉尽责精神，就发行人本次发行事宜出具 《湖南启元律师事务所关于长高电新科技股份公司向不特定对象发行可转换公 司债券的律师工作报告》（以下简称"《律师工作报告》"）和《湖南启元律师 事务所关于长高电新科技股份公司向不特定对象发行可转换公司债券的法律意 见书》（以下简称"本法律意见书"）。 为出具本法律意见书，本所（含本所签字律师）特作如下声明： （一）本所依据《中华人民共和国证券法》《律师事务所从事证券法律业务 管理办法》《律师事务所 ...

Core Viewpoint - Ningbo Xingyuan Zhuomei Technology Co., Ltd. is issuing convertible bonds to unspecified objects, with legal opinions and reports provided by Beijing Deheng Law Firm to ensure compliance with relevant laws and regulations [1][2][3]. Group 1: Company Overview - The main business of the company includes the research, production, and sales of magnesium alloy and aluminum alloy precision die-casting products and supporting die-casting molds [4][5]. - The company operates in the non-ferrous metal casting industry, specifically under the metal products industry category [4]. Group 2: Project Details - The fundraising project aims to produce 3 million sets of high-strength large magnesium alloy precision forming parts, primarily for the automotive sector, including components for new energy vehicles [7][8]. - The project is categorized as "encouraged" under national industrial policies, focusing on lightweight materials for automotive applications [7][8]. Group 3: Compliance and Regulatory Aspects - The project does not fall under obsolete or restricted industries and complies with national industrial policies [8][12]. - The project has met local energy consumption dual control requirements and has obtained the necessary energy-saving review opinions [19][20]. - The project has undergone the required environmental impact assessment and received approval from the relevant environmental authorities [22].

Group 1 - The company, Ningbo Xingyuan Zhuomai Technology Co., Ltd., has received an inquiry letter from the Shenzhen Stock Exchange regarding its application to issue convertible bonds to unspecified objects [1][2] - The company has updated its application documents, including financial data, in response to the inquiry letter and has disclosed these updates on the Giant Tide Information Network [2] - The issuance of convertible bonds is subject to approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission, with uncertainties regarding the approval timeline [2] Group 2 - The company assures that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1] - The company will continue to fulfill its information disclosure obligations in accordance with relevant regulations as the situation progresses [2]

证券代码：603037 证券简称：凯众股份 公告编号：2025-034 上海凯众材料科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 上海凯众材料科技股份有限公司（以下简称"公司"）第四届董事会第二十五 次会议于 2025 年 8 月 12 日（星期二）在上海市浦东新区建业路 813 号公司会议 室以现场结合通讯的方式召开。本次会议应出席董事 9 人，实际出席董事 9 人。 会议由董事长杨建刚先生主持，监事、部分高管列席。会议召开符合有关法 律、法规、规章和《公司章程》的规定。经各位董事认真审议，会议形成了如下 决议： 二、董事会会议审议情况 （一）审议通过《关于进一步明确公司向不特定对象发行可转换公司债券方 案的议案》 公司已收到中国证券监督管理委员会出具的《关于同意上海凯众材料科技 股份有限公司向不特定对象发行可转换公司债券注册的批复》（证监许可 [2025]1244 号），同意公司向不特定对象发行可转换公司债券（以下简称"本次 发行"）的注册申请。公司董事会根据 2023 年年度股 ...

Group 1 - The company announced adjustments to its plan for issuing convertible bonds to unspecified objects, including changes to the total amount of funds to be raised and their intended use [1][2][3] - The total amount of the convertible bonds to be issued has been revised from a maximum of RMB 886 million to a maximum of RMB 872 million [2][3] - The intended use of the raised funds has been detailed, with the total investment amount for projects being RMB 911.2762 million, and the adjusted amount for the bond issuance being RMB 872 million [3][4] Group 2 - The company held multiple board meetings to review and approve the revised bond issuance plan, with the latest meeting occurring on August 8, 2025 [2][5] - The adjustments made to the bond issuance plan include revisions to the fundraising scale and the allocation of funds, which have been disclosed on the Shanghai Stock Exchange website [4][6] - The company emphasized that the bond issuance plan is subject to approval by the shareholders' meeting and regulatory authorities, including the China Securities Regulatory Commission [5][6]

Meeting Overview - The 19th meeting of the 5th Supervisory Board of Jiangxi Sanxin Medical Technology Co., Ltd. was held on August 7, 2025, in compliance with relevant laws and regulations [1][2]. Financial Reporting - The Supervisory Board approved the company's 2025 semi-annual report, confirming that the report accurately reflects the company's actual situation without any false records or omissions [1][3]. Profit Distribution Plan - The company proposed a mid-term profit distribution plan, which includes a cash dividend of 1 yuan (including tax) for every 10 shares based on a total of 522,237,525 shares, after deducting 160,000 shares held in the repurchase account [2][3]. Stock Incentive Plan - The Supervisory Board approved the achievement of conditions for the first unlock period of the 2024 restricted stock incentive plan, allowing 112 eligible participants to unlock a total of 3,849,575 shares [3][4]. Convertible Bond Issuance - The company confirmed its eligibility to issue convertible bonds to unspecified investors, with a total fundraising target of up to 530 million yuan [5][6]. - The convertible bonds will be issued at face value, with a term of six years and an annual interest payment structure [6][7]. Fund Utilization - The proceeds from the bond issuance will be allocated to projects including the expansion of blood dialysis membrane production and the construction of high-performance blood purification equipment production lines, totaling 530 million yuan [17][18]. Governance and Compliance - The company established rules for the bondholders' meeting and outlined measures to mitigate the dilution of immediate returns for existing shareholders due to the bond issuance [21][22].